• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎静默性低氧血症:发病机制与可能的管理策略。

Silent hypoxia in COVID-19: pathomechanism and possible management strategy.

机构信息

Biotechnology Program, Department of Mathematics and Natural Sciences, School of Data and Sciences, Brac University, Dhaka, Bangladesh.

Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh.

出版信息

Mol Biol Rep. 2021 Apr;48(4):3863-3869. doi: 10.1007/s11033-021-06358-1. Epub 2021 Apr 23.

DOI:10.1007/s11033-021-06358-1
PMID:33891272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8062941/
Abstract

The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although the prevalence of silent hypoxia in COVID-19 patients has been evident in several cases, the underlying pathomechanism behind this condition is still unclear. Silent hypoxia in SARS-CoV-2 infected patients can be diagnosed with the help of a pulse oximeter, blood gas levels, and a 6-min walking test. While the clinicians and researchers figure out the exact reason for this phenomenon, the patients must be under strict day-to-day monitoring. In this article, we aim to provide comprehensive insights into the underlying symptoms, mechanism, and possible factors behind the occurrence of silent hypoxia among COVID-19 patients.

摘要

新型冠状病毒病 2019(COVID-19)已成为严重的健康问题,尤其是对于那些在 SARS-CoV-2 感染后出现无症状低氧血症的患者。由于这些患者没有呼吸困难且血氧饱和度极低,因此他们面临极高的风险。尽管 COVID-19 患者出现无症状低氧血症的情况已经在多个病例中得到证实,但这种情况背后的潜在病理机制仍不清楚。SARS-CoV-2 感染患者的无症状低氧血症可以通过脉搏血氧仪、血气水平和 6 分钟步行试验来诊断。在临床医生和研究人员找出这种现象的确切原因的同时,患者必须接受严格的日常监测。在本文中,我们旨在提供对 COVID-19 患者无症状低氧血症发生的潜在症状、机制和可能因素的全面了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f4/8062941/f103cd749273/11033_2021_6358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f4/8062941/938b807a1e5e/11033_2021_6358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f4/8062941/f103cd749273/11033_2021_6358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f4/8062941/938b807a1e5e/11033_2021_6358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4f4/8062941/f103cd749273/11033_2021_6358_Fig2_HTML.jpg

相似文献

1
Silent hypoxia in COVID-19: pathomechanism and possible management strategy.新型冠状病毒肺炎静默性低氧血症:发病机制与可能的管理策略。
Mol Biol Rep. 2021 Apr;48(4):3863-3869. doi: 10.1007/s11033-021-06358-1. Epub 2021 Apr 23.
2
Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review.新型冠状病毒肺炎患者的静默性低氧血症:综述。
Med Sci Monit. 2021 Oct 12;27:e930776. doi: 10.12659/MSM.930776.
3
Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.静默性低氧血症:COVID-19 患者临床恶化的先兆。
Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6. doi: 10.1016/j.ajem.2020.05.044. Epub 2020 May 22.
4
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?新冠病毒患者目标血氧饱和度的考虑因素:我们是否设定得过低?
BMC Med. 2020 Aug 19;18(1):260. doi: 10.1186/s12916-020-01735-2.
5
Clinical and radiological findings of silent hypoxia among COVID-19 patients.新型冠状病毒肺炎患者静默低氧血症的临床和影像学特征。
J Infect Chemother. 2021 Oct;27(10):1536-1538. doi: 10.1016/j.jiac.2021.07.002. Epub 2021 Jul 8.
6
[Pulse oximetry: Role in the COVID-19 patient at home].[脉搏血氧饱和度测定:在居家新冠患者中的作用]
Semergen. 2022 Jan-Feb;48(1):70-77. doi: 10.1016/j.semerg.2021.03.004. Epub 2021 Apr 20.
7
An Evolving Clinical Need: Discordant Oxygenation Measurements of Intubated COVID-19 Patients.不断变化的临床需求:气管插管 COVID-19 患者的氧合测量结果不一致。
Ann Biomed Eng. 2021 Mar;49(3):959-963. doi: 10.1007/s10439-020-02722-7. Epub 2021 Jan 19.
8
Early Detection of Silent Hypoxia in Covid-19 Pneumonia Using Smartphone Pulse Oximetry.使用智能手机脉搏血氧仪早期检测新冠病毒肺炎中的沉默性低氧血症
J Med Syst. 2020 Jun 19;44(8):134. doi: 10.1007/s10916-020-01587-6.
9
Silent Hypoxia in COVID-19 Pneumonia: State of Knowledge, Pathophysiology, Mechanisms, and Management.新型冠状病毒肺炎中的静默性低氧血症:知识现状、病理生理学、机制和管理。
AACN Adv Crit Care. 2022 Jun 15;33(2):143-153. doi: 10.4037/aacnacc2022448.
10
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study.2019冠状病毒病中的沉默性低氧血症:它更危险吗?——一项回顾性队列研究。
Lung India. 2022 May-Jun;39(3):247-253. doi: 10.4103/lungindia.lungindia_601_21.

引用本文的文献

1
Prognostic value of novel indices combining Shock Index, Reverse Shock Index, age, and oxygen saturation for predicting mortality in COVID-19 patients in Iran at emergency department triage: a cross-sectional study.急诊科分诊时,新型指标(结合休克指数、反向休克指数、年龄和血氧饱和度)对预测伊朗COVID-19患者死亡率的预后价值:一项横断面研究。
Acute Crit Care. 2025 Aug;40(3):425-434. doi: 10.4266/acc.005040. Epub 2025 Aug 29.
2
Advances in gas-exchange physiology and pathophysiology.气体交换生理学与病理生理学的进展
ERS Monogr. 2025 Apr;2025:12-31. doi: 10.1183/2312508x.10006124.
3
HIF-1α Pathway in COVID-19: A Scoping Review of Its Modulation and Related Treatments.

本文引用的文献

1
Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient.肺泡萎陷硬结是一名新冠肺炎患者的超微结构表现。
Eur Respir J. 2021 May 6;57(5). doi: 10.1183/13993003.04165-2020. Print 2021 May.
2
COVID-19: efficacy of prehospital pulse oximetry for early detection of silent hypoxemia.新型冠状病毒肺炎:院前脉搏血氧饱和度测定对隐匿性低氧血症早期检测的有效性
Crit Care. 2020 Aug 13;24(1):501. doi: 10.1186/s13054-020-03185-x.
3
Pulse Oximetry as a Biomarker for Early Identification and Hospitalization of COVID-19 Pneumonia.
COVID-19中的HIF-1α通路:对其调节及相关治疗的综述
Int J Mol Sci. 2025 Apr 28;26(9):4202. doi: 10.3390/ijms26094202.
4
Chest computed tomography and plain radiographs demonstrate vascular distribution and characteristics in COVID-19 lung disease - a pulmonary vasculopathy.胸部计算机断层扫描和X线平片显示了新型冠状病毒肺炎肺部疾病(一种肺血管病变)中的血管分布及特征。
Ulster Med J. 2025 Apr;94(1):4-12. Epub 2025 Apr 30.
5
Acute COVID-19 and LongCOVID syndrome - molecular implications for therapeutic strategies - review.急性新冠病毒感染与新冠长期症状综合征——治疗策略的分子影响——综述
Front Immunol. 2025 Apr 17;16:1582783. doi: 10.3389/fimmu.2025.1582783. eCollection 2025.
6
Understanding chronic inflammation: couplings between cytokines, ROS, NO, Ca , HIF-1α, Nrf2 and autophagy.理解慢性炎症:细胞因子、活性氧、一氧化氮、钙离子、低氧诱导因子-1α、核因子E2相关因子2与自噬之间的相互关系
Front Immunol. 2025 Apr 8;16:1558263. doi: 10.3389/fimmu.2025.1558263. eCollection 2025.
7
Incidence and predictive factors of hyperventilation syndrome in patients after COVID 19 pneumonia: a prospective cohort study.新冠病毒肺炎后患者过度通气综合征的发病率及预测因素:一项前瞻性队列研究
F1000Res. 2024 Dec 6;13:1497. doi: 10.12688/f1000research.152196.1. eCollection 2024.
8
Progress in research on osteoporosis secondary to SARS-CoV-2 infection.新型冠状病毒肺炎继发骨质疏松症的研究进展
Animal Model Exp Med. 2025 May;8(5):829-841. doi: 10.1002/ame2.12573. Epub 2025 Mar 3.
9
Retrospective longitudinal study on the long-term impact of COVID-19 infection on polysomnographic evaluation in patients with Prader-Willi syndrome.关于新冠病毒感染对普拉德-威利综合征患者多导睡眠图评估的长期影响的回顾性纵向研究。
Orphanet J Rare Dis. 2024 Dec 13;19(1):461. doi: 10.1186/s13023-024-03447-9.
10
V-V ECMO for severe Chlamydia psittaci pneumonia presenting with sudden cardiac arrest: A case report and literature review.V-V ECMO 治疗鹦鹉热衣原体肺炎致心跳骤停 1 例并文献复习
Medicine (Baltimore). 2024 Nov 8;103(45):e39808. doi: 10.1097/MD.0000000000039808.
脉搏血氧饱和度作为新冠病毒肺炎早期识别及住院治疗的生物标志物
Acad Emerg Med. 2020 Aug;27(8):785-786. doi: 10.1111/acem.14052. Epub 2020 Aug 16.
4
Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge.SARS CoV-2 感染患者出院前的静默性低血氧症。
Int J Infect Dis. 2020 Oct;99:100-101. doi: 10.1016/j.ijid.2020.07.014. Epub 2020 Jul 11.
5
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure.COVID-19 导致的血管内皮损伤:补体、HIF-1 和 ABL2 是损伤的潜在途径和治疗靶点。
Ann Hematol. 2020 Aug;99(8):1701-1707. doi: 10.1007/s00277-020-04138-8. Epub 2020 Jun 24.
6
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.新型 SARS-CoV-2 病毒感染者的实验室特征。
J Infect. 2020 Aug;81(2):205-212. doi: 10.1016/j.jinf.2020.06.039. Epub 2020 Jun 21.
7
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?危重症COVID-19患者的高铁蛋白血症——铁蛋白是炎症产物还是致病介质?
Clin Chim Acta. 2020 Oct;509:249-251. doi: 10.1016/j.cca.2020.06.033. Epub 2020 Jun 21.
8
Early Detection of Silent Hypoxia in Covid-19 Pneumonia Using Smartphone Pulse Oximetry.使用智能手机脉搏血氧仪早期检测新冠病毒肺炎中的沉默性低氧血症
J Med Syst. 2020 Jun 19;44(8):134. doi: 10.1007/s10916-020-01587-6.
9
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.为什么 COVID-19 静默性低氧血症让医生感到困惑。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):356-360. doi: 10.1164/rccm.202006-2157CP.
10
Pulse Oximetry for Monitoring Patients with COVID-19 at Home. Potential Pitfalls and Practical Guidance.脉氧仪在家中监测 COVID-19 患者:潜在陷阱与实用指南。
Ann Am Thorac Soc. 2020 Sep;17(9):1040-1046. doi: 10.1513/AnnalsATS.202005-418FR.